Optimal conditions for storing blood samples for assessing the hemocompatibility of medical devices in vitro

The purpose of the work is to establish optimal storage conditions for heparinized human whole blood before launching it into dynamic in vitro test systems of artificial blood flow to assess the hemocompatibility of medical devices.

To conduct the study, blood was collected from donors in a volume of 150 ml using a butterfly needle with a luer-adapter, a catheter and a syringe filled with heparin (1.5 IU/ml). Subsequently, heparinized blood was transferred into test tubes and kept in a thermostat at temperatures of 20, 25, 30 and 37 oC for 40, 50 and 60 minutes, simulating room temperature and human body temperature. As a control sample, solid blood obtained immediately after its fence in donors was used, with the addition of heparin. To study the effect of time and temperature of blood storage on its activation, a number of hematological and immunoenzyme parameters were studied.

Storing whole blood at room temperature initiated activation of platelets and coagulation mechanisms within 60 minutes. The effect of elevated temperatures of 30 and 37 oC was characterized by a statistically significant increase in the content of indicators such as beta-thromboglobulin (by 2.2–2.3 times), thromboxane B2 (by 2.0–2.1 times), prothrombin F1+2 (by 1.6– 1.8 times) and thrombin-antithrombin complex III (by 1.8–2.0 times) after 40 minutes of storage.

It was experimentally established that to assess the hem-proposal of medical products with optimal storage conditions for solid heparinized blood of a person is a storage time of not more than 50 minutes and room temperature of 20–25 °C. The data obtained will help improve the reliability of assessing the blood compatibility of medical devices and, as a result, reduce the risk of adverse consequences for patients.

1. Link A., Cattaneo G., Brynda E., Riedel T., Kucerova J., Schlensak Ch., Wendel H. P., Krajewski S., Michel T. Hemocompatibility testing of blood-contacting implants in a flow loop model mimicking human blood flow. Journal of Visualized Experiments, 2020, vol. 157, p. e60610. https://doi.org/10.3791/60610-v

2. Bhatt A., Renjith N. Product evaluation: blood compatibility studies. Biomedical Product and Materials Evaluation. Sawston, Cambridge, 2022, pp. 435–459.

3. Schmaier A. H. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities. Thrombosis and Haemostasis, 2016, vol. 14, no. 1, pp. 28–39. https://doi.org/10.1111/jth.13194

4. Liu Y. In vitro hemocompatibility evaluation of poly (4-hydroxybutyrate) scaffold. International. Journal of Clinical and Experimental Medicine, 2014, vol. 7, no. 5, pp. 1233–1243.

5. Bai M. Y., Chang Y. C., Chu J. P. Preclinical studies of non-stick thin film metallic glass-coated syringe needles. Scientific Reports, 2020, vol. 10, no. 1, art. 20313. https://doi.org/10.1038/s41598-020-77008-y

6. Jaffer I. H., Weitz J. I. The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem. Acta Biomaterialia, 2019, vol. 94, pp. 2–10. https://doi.org/10.1016/j.actbio.2019.06.021

7. Braune S., Lendlein A., Jung F. Developing standard and test protocols for testing the hemocompatibility of biomaterials. Hemocompatibility of biomaterials for clinical applications: blood – biomaterials interaction. Duxford, UK, 2018, pp. 51–65.

8. Hrynchak V. A., Sychik S. I. Peculiarities of toxic effects produced by diisononyl phthalate and regulation over it in polymer materials and medical products. Health Risk Analysis, 2020, no. 1, pp. 118–125. https://doi.org/10.21668/health.risk/2020.1.13.eng

9. Drozdova E. V., Sychik S. I., Hrynchak V. A., Rjabceva S. N. Experimental models of animal chronic pathology in assessing health risks for sensitive population groups. Health Risk Analysis, 2022, no. 2, pp. 185–195. https://doi.org/10.21668/health.risk/2022.2.17.eng

10. Wacker M., Betke U., Borucki K., Hülsmann J., Awad G., Varghese S., Scherner M., Hansen M., Wippermann J., Veluswamy P. An in vitro hemodynamic loop model to investigate the hemocytocompatibility and host cell activation of vascular medical devices. Journal of Visualized Experiments, 2020, vol. 162, p. e61570. https://doi.org/10.3791/61570

11. Blok L. J. S., Engels G. E., van Oeveren W. In vitro hemocompatibility testing: the importance of fresh blood. Biointerphases, 2016, vol. 11, p. 029802. https://doi.org/10.1116/1.4941850

12. Sarode D. N., Roy S. In vitro models for thrombogenicity testing of blood-recirculating medical devices. Expert Review of Medical Devices, 2019, vol. 16, no. 7, pp. 603–616. https://doi.org/10.1080/17434440.2019.1627199

13. Gerwin E. E., Sjoerd L. J. B., van Willem O. In vitro blood flow model with physiological wall shear stress for hemocompatibility testing – An example of coronary stent testing. Biointerphases, 2016, vol. 11, no. 3, art. 031004. https://doi.org/10.1116/1.4958979

14. Major T., Handa H., Annich G., Bartlett R. Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity. Journal of Biomaterials, 2014, vol. 29, no. 4, pp. 479–501. https://doi.org/10.1177/0885328214538866

15. van Kruchten R., Cosemans J. M., Heemskerk J. W. Measurement of whole blood thrombus formation using parallel-plate flow chambers – a practical guide. Platelets, 2012, vol. 23, no. 3, pp. 229–242. https://doi.org/10.3109/09537104.2011.630848

16. Weber M., Steinle H., Golombek S., Hann L., Schlensak C., Wendel H. P., Avci-Adali M. Blood-contacting biomaterials: In vitro evaluation of the hemocompatibility. Frontiers in Bioengineering and Biotechnology, 2018, vol. 16, no. 6, art. 99. https://doi.org/10.3389/fbioe.2018.00099

17. Long A. T., Kenne E., Jung R., Fuchs T. A., Renné T. Contact system revisited: an interface between inflammation, coagulation, and innate immunity. Journal of Thrombosis and Haemostasis, 2016, vol. 14, no. 3, pp. 427–437. https://doi.org/10.1111/jth.13235

18. Feng L.-A., Shi J., Guo J. Y., Wang S.-F. Recent strategies for improving hemocompatibility and endothelialization of cardiovascular devices and inhibition of intimal hyperplasia. Journal of Materials Chemistry B, 2022, vol. 10, no. 20, pp. 3781–3792. https://doi.org/10.1039/d2tb00478j

19. McNamee A. P., Griffith T. A., Smith A. G., Kuck L., Simmonds M. J. Accelerated hemocompatibility testing of rotary blood pumps. American Society for Artificial Internal Organs Journal, 2023, vol. 69, no. 10, pp. 918–923. https://doi.org/10.1097/MAT.0000000000001995

20. Jonathan W. Y., Stafford A. R., Liao P., Fredenburgh J. C., Roberts R., Weitz J. I. Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Journal Blood, 2011, vol. 118, no. 25, pp. 6667–6674. https://doi.org/10.1182/blood-2011-07-364141